Hyuk Sung Kwon; Seong‐Ho Koh · 2020 · Translational Neurodegeneration
Paper
Neuroinflammation is associated with neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. Microglia and astrocytes are key regulators of inflammatory responses in the central nervous system. The activation of microglia and astrocytes is heterogeneous and traditionally categorized as neurotoxic (M1-phenotype microglia and A1-phenotype astrocytes) or neuroprotective (M2-phenotype microglia and A2-phenotype astrocytes). However, this dichotomized classification may not reflect the various phenotypes of microglia and astrocytes. The relationship between these activated glial cells is also very complicated, and the phenotypic distribution can change, based on the progression of neurodegenerative diseases. A better understanding of the roles of microglia and astrocytes in neurodegenerative diseases is essential for developing effective therapies. In this review, we discuss the roles of inflammatory response in neurodegenerative diseases, focusing on the contributions of microglia and astrocytes and their relationship. In addition, we discuss biomarkers to measure neuroinflammation and studies on therapeutic drugs that can modulate neuroinflammation.
Analysis
This review explores the complex roles of microglia and astrocytes in neuroinflammation associated with neurodegenerative diseases like Alzheimer's, Parkinson's, and ALS.
Discovery
John Chulhoon Park; Leechung Chang; Ho‐Keun Kwon; Sin‐Hyeog Im
Kenneth J. O’Riordan; Gerard M. Moloney; Lily Keane; Gerard Clarke; John F. Cryan
Renqing Zhao
Echo Yongqi Luo; Rio Ryohichi Sugimura
Anbiao Wu; Jiyan Zhang
Weifeng Zhang; Dan Xiao; Qinwen Mao; Haibin Xia
Source record